Stromal Therapeutics
Stromal Therapeutics is the first biotechnological spin-off from the Kantonsspital St.Gallen. Stromal Therapeutics Building on the group’s unique domain expertise, the company has deployed state-of-the-art single-cell sequencing of human tissues to molecularly unravel the interplay of stromal tissue cytokines with the immune system
Domain
stromaltherapeutics.ch
Country
SwitzerlandIndustry
BiotechnologyEmployees
1-10
Last Funding
$0.5M
Founded
2018
Tech Stack (6 technologies)
Frequently Asked Questions
What technologies does Stromal Therapeutics use?+
Stromal Therapeutics uses 6 technologies including Prototype, Modernizr, Strato Website.
What industry is Stromal Therapeutics in?+
Stromal Therapeutics operates in the Biotechnology industry.
Where is Stromal Therapeutics based?+
Stromal Therapeutics is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026